Literature DB >> 19214144

Characterization and analyses of multidrug resistance-associated protein 1 (MRP1/ABCC1) polymorphisms in Chinese population.

Ji-Ye Yin1, Qiong Huang, Youyun Yang, Jian-Ting Zhang, Mei-Zuo Zhong, Hong-Hao Zhou, Zhao-Qian Liu.   

Abstract

OBJECTIVE: To explore the distribution frequencies of four common single nucleotide polymorphisms (SNPs) of MRP1/ABCC1 in a mainland Chinese population and investigate whether these SNPs affect the expression and function of the MRP1/ABCC1.
METHODS: The genotype of 208 healthy volunteers was determined using PCR-restriction fragment length polymorphism. The four candidated SNPs were recreated by site-directed mutagenesis and tested for their effect on MRP1/ABCC1 expression and multidrug resistance function in stable transfected HEK293 and CHO-K1 cell lines. Real-time PCR, western blot and confocal microscopy were used to determine the mRNA, protein expression, and protein trafficking. At last, the effect of mutations on MRP1/ABCC1-mediate drug resistance was determined using methyl thiazolyl tetrazolium assay.
RESULTS: The allelic frequencies of Cys43Ser (128G>C), Thr73Ile (218C>T), Arg723Gln (2168G>A), and Arg1058Gln (3173G>A) in mainland Chinese were 0.5, 1.4, 5.8, and 0.5%, respectively. None of these mutations had any effect on MRP1/ABCC1 expression and trafficking, but that Arg723Gln mutation significantly reduced MRP1/ABCC1-mediated resistance to daunorubicin, doxorubicin, etoposide, vinblastine, and vincristine. The Cys43Ser mutation did not affect all tested drug resistance. In contrast, the Thr73Ile mutation reduced resistance to methotrexate and etoposide, whereas the Arg1058Gln mutation increased the response of two anthracycline drugs and etoposide in HEK293 and CHO-K1 cells as well as vinblastine and methotrexate in CHO-K1 cells.
CONCLUSION: The allelic frequency of the Arg723Gln mutation is relatively higher than other SNPs in mainland Chinese population and therefore this mutation significantly reduces MRP1/ABCC1 activity in multidrug resistance.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19214144      PMCID: PMC2667206          DOI: 10.1097/FPC.0b013e328323f680

Source DB:  PubMed          Journal:  Pharmacogenet Genomics        ISSN: 1744-6872            Impact factor:   2.089


  24 in total

Review 1.  The ATP switch model for ABC transporters.

Authors:  Christopher F Higgins; Kenneth J Linton
Journal:  Nat Struct Mol Biol       Date:  2004-10       Impact factor: 15.369

2.  Linkage disequilibrium and haplotype architecture for two ABC transporter genes (ABCC1 and ABCG2) in Chinese population: implications for pharmacogenomic association studies.

Authors:  H Wang; B Hao; K Zhou; X Chen; S Wu; G Zhou; Y Zhu; F He
Journal:  Ann Hum Genet       Date:  2004-11       Impact factor: 1.670

Review 3.  Polymorphisms of MRP1 (ABCC1) and related ATP-dependent drug transporters.

Authors:  Gwenaëlle Conseil; Roger G Deeley; Susan P C Cole
Journal:  Pharmacogenet Genomics       Date:  2005-08       Impact factor: 2.089

4.  Functional characterization of non-synonymous single nucleotide polymorphisms in the gene encoding human multidrug resistance protein 1 (MRP1/ABCC1).

Authors:  Isabelle J Létourneau; Roger G Deeley; Susan P C Cole
Journal:  Pharmacogenet Genomics       Date:  2005-09       Impact factor: 2.089

5.  Role of two adjacent cytoplasmic tyrosine residues in MRP1 (ABCC1) transport activity and sensitivity to sulfonylureas.

Authors:  Gwenaëlle Conseil; Roger G Deeley; Susan P C Cole
Journal:  Biochem Pharmacol       Date:  2004-12-16       Impact factor: 5.858

6.  MRP1 mutated in the L0 region transports SN-38 but not leukotriene C4 or estradiol-17 (beta-D-glucuronate).

Authors:  Tomohiro Noguchi; Xiao-Qin Ren; Shunji Aoki; Yoshinobu Igarashi; Xiao-Fang Che; Yuichi Nakajima; Homare Takahashi; Ryoichi Mitsuo; Kazutake Tsujikawa; Tomoyuki Sumizawa; Misako Haraguchi; Motomasa Kobayashi; Susumu Goto; Minoru Kanehisa; Takashi Aikou; Shin-ichi Akiyama; Tatsuhiko Furukawa
Journal:  Biochem Pharmacol       Date:  2005-10-01       Impact factor: 5.858

7.  Pharmacological characterization of the murine and human orthologs of multidrug-resistance protein in transfected human embryonic kidney cells.

Authors:  B D Stride; C E Grant; D W Loe; D R Hipfner; S P Cole; R G Deeley
Journal:  Mol Pharmacol       Date:  1997-09       Impact factor: 4.436

Review 8.  Substrate recognition and transport by multidrug resistance protein 1 (ABCC1).

Authors:  Roger G Deeley; Susan P C Cole
Journal:  FEBS Lett       Date:  2005-12-21       Impact factor: 4.124

9.  Mutational analysis of ionizable residues proximal to the cytoplasmic interface of membrane spanning domain 3 of the multidrug resistance protein, MRP1 (ABCC1): glutamate 1204 is important for both the expression and catalytic activity of the transporter.

Authors:  Donna Situ; Anass Haimeur; Gwenaëlle Conseil; Kathryn E Sparks; Dawei Zhang; Roger G Deeley; Susan P C Cole
Journal:  J Biol Chem       Date:  2004-06-18       Impact factor: 5.157

10.  Expression of multidrug resistance-associated protein in NIH/3T3 cells confers multidrug resistance associated with increased drug efflux and altered intracellular drug distribution.

Authors:  L M Breuninger; S Paul; K Gaughan; T Miki; A Chan; S A Aaronson; G D Kruh
Journal:  Cancer Res       Date:  1995-11-15       Impact factor: 12.701

View more
  28 in total

1.  Promoter polymorphism of MRP1 associated with reduced survival in hepatocellular carcinoma.

Authors:  Jing Zhao; Bing-Yun Yu; Dao-Yuan Wang; Jin-E Yang
Journal:  World J Gastroenterol       Date:  2010-12-28       Impact factor: 5.742

2.  The ATP7B genetic polymorphisms predict clinical outcome to platinum-based chemotherapy in lung cancer patients.

Authors:  Xiang-Ping Li; Ji-Ye Yin; Ying Wang; Hui He; Xi Li; Wei-Jing Gong; Juan Chen; Chen-Yue Qian; Yi Zheng; Fang Li; Tao Yin; Zhi-Cheng Gong; Bo-Ting Zhou; Yu Zhang; Ling Xiao; Hong-Hao Zhou; Zhao-Qian Liu
Journal:  Tumour Biol       Date:  2014-05-23

3.  Doxorubicin pathways: pharmacodynamics and adverse effects.

Authors:  Caroline F Thorn; Connie Oshiro; Sharon Marsh; Tina Hernandez-Boussard; Howard McLeod; Teri E Klein; Russ B Altman
Journal:  Pharmacogenet Genomics       Date:  2011-07       Impact factor: 2.089

4.  Association of Two Polymorphic Codons in P53 and ABCC1 Promoter with Prostate Cancer.

Authors:  Farinaz Behfarjam; Jalal Rostamzadeh; Mohammad Ali Zarei; Bahram Nikkhoo
Journal:  Iran J Biotechnol       Date:  2015-03       Impact factor: 1.671

5.  Translational regulation of RPA2 via internal ribosomal entry site and by eIF3a.

Authors:  Ji-Ye Yin; Zi-Zheng Dong; Ran-Yi Liu; Juan Chen; Zhao-Qian Liu; Jian-Ting Zhang
Journal:  Carcinogenesis       Date:  2013-02-07       Impact factor: 4.944

6.  Association of well-characterized lung cancer lncRNA polymorphisms with lung cancer susceptibility and platinum-based chemotherapy response.

Authors:  Wei-Jing Gong; Ji-Ye Yin; Xiang-Ping Li; Chao Fang; Di Xiao; Wei Zhang; Hong-Hao Zhou; Xi Li; Zhao-Qian Liu
Journal:  Tumour Biol       Date:  2016-01-05

7.  Concentration-dependent effects and intracellular accumulation of HIV protease inhibitors in cultured CD4 T cells and primary human lymphocytes.

Authors:  Omar Janneh; Patrick G Bray; Elizabeth Jones; Christoph Wyen; Peter Chiba; David J Back; Saye H Khoo
Journal:  J Antimicrob Chemother       Date:  2010-03-17       Impact factor: 5.790

Review 8.  Multidrug resistance-associated protein 1 (MRP1/ABCC1) polymorphism: from discovery to clinical application.

Authors:  Jiye Yin; Jianting Zhang
Journal:  Zhong Nan Da Xue Xue Bao Yi Xue Ban       Date:  2011-10

9.  Multidrug resistance gene 1 C1236T polymorphism and susceptibility to leukemia: A meta-analysis.

Authors:  Limin Ma; Hongchao Liu; Linhai Ruan; Xuewen Yang; Haiping Yang; Yanming Feng
Journal:  Biomed Rep       Date:  2014-11-14

10.  Polymorphisms in the multiple drug resistance protein 1 and in P-glycoprotein 1 are associated with time to event outcomes in patients with advanced multiple myeloma treated with bortezomib and pegylated liposomal doxorubicin.

Authors:  Gabriele Buda; Deborah Ricci; C Chris Huang; Reyna Favis; Nadine Cohen; Sen H Zhuang; Jean-Luc Harousseau; Pieter Sonneveld; Joan Bladé; Robert Z Orlowski
Journal:  Ann Hematol       Date:  2010-06-08       Impact factor: 3.673

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.